Zhongchao (NASDAQ:ZCMD) vs. Movano (NASDAQ:MOVE) Head to Head Analysis

Zhongchao (NASDAQ:ZCMD) and Movano (NASDAQ:MOVE) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation and analyst recommendations.

Institutional & Insider Ownership

1.7% of Zhongchao shares are held by institutional investors. Comparatively, 16.6% of Movano shares are held by institutional investors. 28.6% of Zhongchao shares are held by insiders. Comparatively, 10.4% of Movano shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Zhongchao and Movano”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zhongchao	$11.38 million	0.06	-$6.31 million	N/A	N/A
Movano	$430,000.00	49.93	-$18.28 million	($13.74)	-1.38

Zhongchao has higher revenue and earnings than Movano.

Profitability

This table compares Zhongchao and Movano’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Zhongchao	N/A	N/A	N/A
Movano	-2,462.55%	-647.91%	-11.69%

Analyst Recommendations

This is a summary of recent recommendations for Zhongchao and Movano, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zhongchao	1	0	0	0	1.00
Movano	1	0	0	0	1.00

Volatility and Risk

Zhongchao has a beta of -0.13, indicating that its share price is 113% less volatile than the S&P 500. Comparatively, Movano has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500.

Summary

Zhongchao beats Movano on 6 of the 9 factors compared between the two stocks.

About Zhongchao

Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. The company offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. It also provides customized medical courses and medical training services; and patient management services through online platform under the Zhongxun brand. The company operates through its mdmooc.org online platform under the MDMOOC brand; and Sunshine Health Forums, a Wechat subscription account and mobile app. It serves enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. The company was founded in 2012 and is headquartered in Shanghai, China.

About Movano

Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.